Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cells and thyroid autoimmunity

N Tandon1, A P Weetman

  • 1Department of Medicine, University of Sheffield.

Journal of the Royal College of Physicians of London
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I Clinical Study of DOC1021 (dubodencel) for Adjuvant Immunotherapy of Glioblastoma.

medRxiv : the preprint server for health sciences·2026
Same author

Long-term stability and antibacterial efficiency of Cu-Zn co-doped cobalt ferrite-based composites.

Dalton transactions (Cambridge, England : 2003)·2026
Same author

Factors influencing diabetes treatment satisfaction in the INtegrating DEPrEssioN and Diabetes treatmENT randomized clinical trial: A multilevel model analysis.

Diabetic medicine : a journal of the British Diabetic Association·2024
Same author

A global initiative to deliver precision health in diabetes.

Nature medicine·2024
Same author

COVID-19 and tobacco cessation: lessons from India.

Public health·2021
Same author

An update on the pathogenesis of Hashimoto's thyroiditis.

Journal of endocrinological investigation·2020
Same journal

A Change of Government and Its Effect on the NHS Hospital Outpatient Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Erratum: Model for the Organisation of a Community-Based Rehabilitation Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Telemedicine and beyond.

Journal of the Royal College of Physicians of London·2019
Same journal

Palliative Care in General Medicine.

Journal of the Royal College of Physicians of London·2019
Same journal

Medical Negligence.

Journal of the Royal College of Physicians of London·2019
Same journal

In Response.

Journal of the Royal College of Physicians of London·2019
See all related articles

Autoimmune thyroid disease involves T cells. While thyroid cells express HLA-DR, they likely don't initiate autoimmunity because co-stimulation is also needed, making targeted therapies unlikely to succeed.

Area of Science:

  • Immunology
  • Endocrinology
  • Autoimmunity

Background:

  • Autoimmune thyroid disease is a key example of organ-specific autoimmune disorders.
  • Thyroid cells expressing HLA-DR suggested a role in initiating or sustaining autoimmune processes.
  • T cell dependence is a shared characteristic of autoimmune thyroid disease and other organ-specific autoimmune disorders.

Purpose of the Study:

  • To investigate the role of thyroid cells in presenting antigens and initiating autoimmune thyroid disease.
  • To analyze T cell responses to major thyroid antigens and assess the feasibility of targeted treatment strategies.

Main Methods:

  • Functional experiments were conducted to assess antigen presentation by thyroid cells.
  • Analysis of T cell responses to thyroid peroxidase and thyroid stimulating hormone receptor.

Related Experiment Videos

  • Examination of T cell receptor gene usage in intrathyroidal T cells.

    • Main Results:

    • Functional experiments and co-stimulatory signal requirements challenge the hypothesis of thyroid cells initiating autoimmunity.
    • Significant heterogeneity was observed in T cell responses to thyroid antigens within and between patients.
    • Intrathyroidal T cells demonstrated diverse T cell receptor gene usage.

    Conclusions:

    • Thyroid cells are unlikely to initiate or maintain autoimmune thyroid disease due to the necessity of co-stimulatory signals.
    • The heterogeneity in T cell responses and T cell receptor usage complicates targeted therapeutic strategies.
    • Treatments involving modified peptides, monoclonal antibodies, or T cell vaccination are unlikely to be successful for thyroid autoimmunity.